A
Price
$114.37
Change
-$0.25 (-0.22%)
Updated
Aug 11, 04:09 PM (EDT)
Capitalization
32.56B
16 days until earnings call
BLFS
Price
$22.64
Change
+$2.00 (+9.69%)
Updated
Aug 11, 03:30 PM (EDT)
Capitalization
1.09B
87 days until earnings call
Interact to see
Advertisement

A vs BLFS

Header iconA vs BLFS Comparison
Open Charts A vs BLFSBanner chart's image
Agilent Technologies
Price$114.37
Change-$0.25 (-0.22%)
Volume$513
Capitalization32.56B
BioLife Solutions
Price$22.64
Change+$2.00 (+9.69%)
Volume$100
Capitalization1.09B
A vs BLFS Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. BLFS commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and BLFS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (A: $114.62 vs. BLFS: $20.64)
Brand notoriety: A and BLFS are both not notable
A represents the Medical Specialties, while BLFS is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: A: 63% vs. BLFS: 0%
Market capitalization -- A: $32.56B vs. BLFS: $1.09B
A [@Medical Specialties] is valued at $32.56B. BLFS’s [@Pharmaceuticals: Other] market capitalization is $1.09B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $168.51B to $0. The average market capitalization across the [@Medical Specialties] industry is $9.89B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 0 FA rating(s) are green whileBLFS’s FA Score has 1 green FA rating(s).

  • A’s FA Score: 0 green, 5 red.
  • BLFS’s FA Score: 1 green, 4 red.
According to our system of comparison, A is a better buy in the long-term than BLFS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 4 TA indicator(s) are bullish while BLFS’s TA Score has 2 bullish TA indicator(s).

  • A’s TA Score: 4 bullish, 6 bearish.
  • BLFS’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, A is a better buy in the short-term than BLFS.

Price Growth

A (@Medical Specialties) experienced а +0.99% price change this week, while BLFS (@Pharmaceuticals: Other) price change was -0.79% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.95%. For the same industry, the average monthly price growth was +1.72%, and the average quarterly price growth was -1.70%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.20%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was +3.21%.

Reported Earning Dates

A is expected to report earnings on Aug 27, 2025.

BLFS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Specialties (+3.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+2.20% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($32.6B) has a higher market cap than BLFS($1.09B). A YTD gains are higher at: -14.318 vs. BLFS (-20.493). A has higher annual earnings (EBITDA): 1.76B vs. BLFS (2.72M). A has more cash in the bank: 1.49B vs. BLFS (88.6M). BLFS has less debt than A: BLFS (26.9M) vs A (3.5B). A has higher revenues than BLFS: A (6.63B) vs BLFS (87.8M).
ABLFSA / BLFS
Capitalization32.6B1.09B3,002%
EBITDA1.76B2.72M64,788%
Gain YTD-14.318-20.49370%
P/E Ratio28.23N/A-
Revenue6.63B87.8M7,549%
Total Cash1.49B88.6M1,677%
Total Debt3.5B26.9M12,993%
FUNDAMENTALS RATINGS
A vs BLFS: Fundamental Ratings
A
BLFS
OUTLOOK RATING
1..100
5056
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
99
Overvalued
PROFIT vs RISK RATING
1..100
7196
SMR RATING
1..100
4792
PRICE GROWTH RATING
1..100
6180
P/E GROWTH RATING
1..100
6914
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (47) in the Biotechnology industry is somewhat better than the same rating for BLFS (99) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than BLFS’s over the last 12 months.

A's Profit vs Risk Rating (71) in the Biotechnology industry is in the same range as BLFS (96) in the Medical Specialties industry. This means that A’s stock grew similarly to BLFS’s over the last 12 months.

A's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for BLFS (92) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than BLFS’s over the last 12 months.

A's Price Growth Rating (61) in the Biotechnology industry is in the same range as BLFS (80) in the Medical Specialties industry. This means that A’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's P/E Growth Rating (14) in the Medical Specialties industry is somewhat better than the same rating for A (69) in the Biotechnology industry. This means that BLFS’s stock grew somewhat faster than A’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABLFS
RSI
ODDS (%)
Bearish Trend 4 days ago
46%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 4 days ago
56%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
65%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
63%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 26 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
60%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
63%
Bearish Trend 7 days ago
76%
Aroon
ODDS (%)
Bullish Trend 4 days ago
67%
Bearish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OMSOX29.730.18
+0.61%
Invesco Main Street All Cap A
SBICX10.080.06
+0.60%
ClearBridge International Value C
FCUDX20.150.12
+0.60%
NYLI PineStone U.S. Equity Class R6
PRJBX46.160.13
+0.28%
PGIM Jennison Global Opportunities R2
RYLCX74.07-0.65
-0.87%
Rydex Leisure C